HIV protease inhibitors (Searle)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHIV protease inhibitors (Searle)
Drug Alias Nameanti-HIV (Searle)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV protease inhibitors
TargetsHIV protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued
Highest Status in ChinaN/A
Originator CompaniesG. D. Searle & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesG. D. Searle & Co
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A